Table 1.

Patients with polycythemia

NumberSexAgePCVDiagnosis
PV1 59 47 polycythemia vera  
PV2 69 46 polycythemia vera 
PV3 52 44 polycythemia vera 
PV4 69 49 polycythemia vera 
PV5 68 50 polycythemia vera 
PV6 49 46 polycythemia vera 
PV7 72 45 polycythemia vera 
PV8 46 47 polycythemia vera 
PV9 61 46 polycythemia vera 
PV10 69 48 polycythemia vera 
PV11 74 50 polycythemia vera 
PV12 61 48 polycythemia vera 
SP1 49 54 hemoglobin with increased oxygen affinity 
SP2 48 57 carbon monoxide toxicity 
SP3 68 59 testosterone treatment for impotence 
SP4 60 53 carbon monoxide toxicity 
SP5 70 53 carbon monoxide toxicity 
SP6 57 52 carbon monoxide toxicity 
NumberSexAgePCVDiagnosis
PV1 59 47 polycythemia vera  
PV2 69 46 polycythemia vera 
PV3 52 44 polycythemia vera 
PV4 69 49 polycythemia vera 
PV5 68 50 polycythemia vera 
PV6 49 46 polycythemia vera 
PV7 72 45 polycythemia vera 
PV8 46 47 polycythemia vera 
PV9 61 46 polycythemia vera 
PV10 69 48 polycythemia vera 
PV11 74 50 polycythemia vera 
PV12 61 48 polycythemia vera 
SP1 49 54 hemoglobin with increased oxygen affinity 
SP2 48 57 carbon monoxide toxicity 
SP3 68 59 testosterone treatment for impotence 
SP4 60 53 carbon monoxide toxicity 
SP5 70 53 carbon monoxide toxicity 
SP6 57 52 carbon monoxide toxicity 

Patients with PV were treated only with phlebotomy except PV7, who received 1000 mg hydroxyurea per day. PV10 and PV11 received32P in 1997, but subsequently relapsed and were being phlebotomized. All patients with SP were treated only with phlebotomy.

PV indicates polycythemia vera; SP, secondary polycythemia.

Close Modal

or Create an Account

Close Modal
Close Modal